GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co Ltd (GenSci) is one of the largest, most profitable and rapidly-growing biopharmaceutical companies in China, with 7 products on the market and over 10 products in the pipeline. GenSci's business is focused on developing, manufacturing and marketing biologics as well as innovative biogenerics. GenSci was awarded the first "Medical Center for Quality Controls of Genetic Engineering Pharmaceuticals" by Chinese Quality Association of Pharmaceuticals (CQAP) in 2007, and the first state genetic engineering "Enterprise's New Drug incubation base" & the state New Drug R&D Major Project of "Eleventh Five-Year Plan" in 2009. GenSci has achieved sustainable successes with rapid growth rates in the past twenty years. One of GenSci's important products, GenLei Jintropin (rhGH, Somatropin for Injection) has been the leading brand of rhGH in China with a dominant market share since launched in 1998.
|Sales markets||Middle East, Asia, Central/South America|
|Affiliated categories:||Bio-similars |Biopharmaceuticals (general category) |Generic Hormones & Synthetic Substances More|
CPhI Worldwide 20189 - 11 October 2018 Madrid, Spain We were at stand 12A33 See our Exhibitor Profile See full Exhibitor List
Our Top products
Polyethylene Glycol Somatropin Injection
Jintrolong, used for Children GHD, AGHD and burns.More info
Scimax, used for Neutropenia induced by chemotherapy of cancer treatment and bone marrow transplantation.More info
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation